First patient enrolled in AVITA Therapeutic’s pivotal study evaluating the RECELL system for repigmentation of stable vitiligo

First patient enrolled in AVITA Therapeutic’s study for RECELL system. (Credit: Wikipedia.org/James Heilman, MD.)



Related Article
Recommended Whitepaper

View More